TQS-168

N/A

Report date: 2025/06/05 16:57:54
NME

Base Information

Drug NameTQS-168
Drug Alias NameTQS-168ZLN-005
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPeroxisome proliferator-activated receptor gamma coactivator 1-alpha modulatorsNAD-dependent deacetylase sirtuin 1 modulators
TargetsPeroxisome proliferator-activated receptor gamma coactivator 1-alphaNAD-dependent deacetylase sirtuin 1
Therapy Area/IndicationsNerve DegenerationDiabetes MellitusAmyotrophic Lateral Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited KingdomMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPreclinical
Originator CompaniesTranquis Therapeutics IncChinese Academy Of Sciences
China Registration ClassN/A

Develop Information

Active CompaniesTranquis Therapeutics IncFourth Military Medical University Of Chinese People'S Liberation Army
Inactive CompaniesN/A
Active IndicationsNerve DegenerationDiabetes MellitusAmyotrophic Lateral Sclerosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A